{"id":311536,"date":"2026-10-15T17:31:29","date_gmt":"2026-10-15T12:01:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=311536"},"modified":"2026-10-15T17:31:29","modified_gmt":"2026-10-15T12:01:29","slug":"icici-life-shares-fall-34-percent-in-2026-but-religare-sees-42-percent-upside-why","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/icici-life-shares-fall-34-percent-in-2026-but-religare-sees-42-percent-upside-why\/","title":{"rendered":"ICICI Life Shares Fall 34% in 2026, but Religare Sees 42% Upside | Why?"},"content":{"rendered":"

ICICI Life shares fell about 3.4% to about Rs 447 on 13 Oct 2026, close to the 52-week low of Rs 441.80 and about 37% below the 52-week high of Rs 706.80. H1 FY27 VNB rose 22.3% to Rs 1,283 crore and the VNB margin rose to 26.0%. Elara upgraded to Buy with a target of Rs 600, about 34% above Rs 447. I could not find the Religare note, so its 42% upside is unverified.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

ICICI Life shares are down about 34% in 2026 even as the insurer reported higher profit and a better VNB margin for H1 FY27. H1 FY27 value of new business (VNB) rose 22.3% to Rs 1,283 crore and the VNB margin rose to 26.0%, while Q2 net profit rose 25% to Rs 374.22 crore. The share price fell on worries about the product mix, weaker long term persistency and the uncertainty over commission rules, and Elara upgraded the stock to Buy on 13 October with a target of Rs 600. I could not find the Religare note, so its 42% upside is unverified, but my calculation shows that figure would imply a target near Rs 635 from Rs 447.<\/p>\n<\/p><\/div>\n

ICICI Life, formerly ICICI Prudential Life Insurance, is one of the largest private life insurers, and its share price has fallen to the lowest level in a year. The headline asks why a stock that grows profit by 25% is at a 52-week low, and why one brokerage sees a 42% rise.<\/p>\n

This guide covers the Q2 and H1 FY27 numbers of ICICI Life, the reasons for the fall, what brokerages say, and the risks. It is not a recommendation to buy or sell.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n